Clinical trial
Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head…
NCT00030576 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00030576 |
|---|---|
| Title | Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
| Official title | A Phase I/II Study Of OSI-774 In Combination With Cisplatin In Patients With Recurrent Or Metastatic Squamous Cell Cancer Of The Head And Neck |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, erlotinib hydrochloride |
| Enrollment | 51 |
| Start date | Nov 1, 2001 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 10, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: